Pharmaceutical Pricing Policies in Italy
- 28 November 2014
- book chapter
- Published by Springer Nature
- p. 131-150
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)BMJ Open, 2013
- Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersHealth Policy, 2010
- Co-payments and the demand for pharmaceuticals: Evidence from ItalyEconomic Modelling, 2010
- Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providersAnnals of Oncology, 2010
- Governing decentralization in health care under tough budget constraint: What can we learn from the Italian experience?Health Policy, 2009
- The Last Decade of Italian Pharmaceutical PolicyPharmacoEconomics, 2008
- Public administration and R&D localisation by pharmaceutical and biotech companies: A theoretical framework and the Italian case-studyHealth Policy, 2006
- Off-patent drugs in ItalyThe European Journal of Health Economics, 2006
- Pharmaceutical policy in Italy: towards a structural change?Health Policy, 2005
- New funding arrangements in the Italian National Health ServiceThe International Journal of Health Planning and Management, 2001